Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 107
of 6Next
1:

Predictive validity of a brief antiretroviral adherence index: Retrospective cohort analysis under conditions of repetitive administration.

Mathews WC, Barker E, Winter E, Ballard C, Colwell B, May S.

AIDS Res Ther. 2008 Aug 29;5:20.

PMID: 18759989 [PubMed - in process]

2:

Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.

Martin M, Del Cacho E, Codina C, Tuset M, De Lazzari E, Mallolas J, Miró JM, Gatell JM, Ribas J.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1263-8.

PMID: 18834323 [PubMed - indexed for MEDLINE]

3:

Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, Bangsberg DR.

PLoS ONE. 2008 Jul 30;3(7):e2783.

PMID: 18665246 [PubMed - indexed for MEDLINE]

4:

Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.

Glass TR, De Geest S, Hirschel B, Battegay M, Furrer H, Covassini M, Vernazza PL, Bernasconi E, Rickenboch M, Weber R, Bucher HC; Swiss HIV Cohort Study.

Antivir Ther. 2008;13(1):77-85.

PMID: 18389901 [PubMed - indexed for MEDLINE]

5:

Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.

Jaspan HB, Berrisford AE, Boulle AM.

Pediatr Infect Dis J. 2008 Nov;27(11):993-8.

PMID: 18818556 [PubMed - indexed for MEDLINE]

6:

Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression.

Boyle BA, Jayaweera D, Witt MD, Grimm K, Maa JF, Seekins DW.

HIV Clin Trials. 2008 May-Jun;9(3):164-76.

PMID: 18547903 [PubMed - indexed for MEDLINE]

7:

Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa.

Müller AD, Bode S, Myer L, Roux P, von Steinbüchel N.

Pediatr Infect Dis J. 2008 Mar;27(3):257-62.

PMID: 18277933 [PubMed - indexed for MEDLINE]

8:

Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.

Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G.

AIDS. 2008 Oct 18;22(16):2117-25.

PMID: 18832875 [PubMed - in process]

9:

Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.

Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ.

CNS Drugs. 2008;22(11):963-73.

PMID: 18840035 [PubMed - in process]

10:

Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy.

Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV.

Health Psychol. 2008 Mar;27(2):159-69.

PMID: 18377134 [PubMed - indexed for MEDLINE]

11:

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.

Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.

AIDS. 2008 Nov 12;22(17):2371-80.

PMID: 18981777 [PubMed - in process]

13:

Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.

Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Chatham A, Raper JL, Kaslow RA, Saag MS, Mugavero MJ.

AIDS. 2008 Oct 1;22(15):1951-60.

PMID: 18784459 [PubMed - indexed for MEDLINE]

14:

Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis.

Reynolds NR, Sun J, Nagaraja HN, Gifford AL, Wu AW, Chesney MA.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):402-9.

PMID: 18077832 [PubMed - indexed for MEDLINE]

15:

Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy.

Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, Limbada M, Taylor A, Saag MS, Vermund SH, Stringer JS, Chi BH.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1031-5.

PMID: 18724803 [PubMed - indexed for MEDLINE]

16:

Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study.

United Kingdom Collaborative HIV Cohort Study, Lee KJ, Dunn D, Porter K, Bansi RG, Hill T, Phillips AN, Sabin CA, Schwenk A, Leen C, Delpech V, Anderson J, Gazzard B, Johnson M, Easterbrook P, Walsh J, Fisher M, Orkin C.

AIDS. 2008 Oct 1;22(15):1943-50.

PMID: 18784458 [PubMed - indexed for MEDLINE]

17:

How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?

Gross R, Bilker WB, Wang H, Chapman J.

HIV Clin Trials. 2008 May-Jun;9(3):202-6.

PMID: 18547907 [PubMed - indexed for MEDLINE]

18:

Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression.

Saberi P, Caswell N, Amodio-Groton M, Alpert P.

AIDS Care. 2008 Jul;20(6):741-5.

PMID: 18576177 [PubMed - indexed for MEDLINE]

19:

Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.

Kouanfack C, Laurent C, Peytavin G, Ciaffi L, Ngolle M, Nkene YM, Essomba C, Calmy A, Mpoudi-Ngolé E, Delaporte E, Koulla-Shiro S; French National Agency for Research on AIDS 1274 Study Group.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):216-9.

PMID: 18520681 [PubMed - indexed for MEDLINE]

20:

Self-report adherence measures in chronic illness: retest reliability and predictive validity.

Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P.

Med Care. 2008 Nov;46(11):1134-9.

PMID: 18953223 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 107
of 6Next